Eton Pharmaceuticals, Inc. (ETON) Financials

ETON Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 97.7 million 67.1 million
Dec. 31, 2025 92.1 million 66.0 million
Sept. 30, 2025 104.5 million 81.4 million
June 30, 2025 101.7 million 77.7 million

ETON Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 7.3 million 1.5 million
Dec. 31, 2025 -11.6 million 1.1 million
Sept. 30, 2025 11.7 million 1.1 million
June 30, 2025 8.0 million 2.1 million

ETON Net Income

No data available :(

ETON Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 19.7 million 440000 440000
Dec. 31, 2025 25.9 million 460000 460000
Sept. 30, 2025 37.1 million 480000 480000
June 30, 2025 25.4 million 27.4 million 492000

ETON Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 31.5 million
Dec. 31, 2025 26.9 million
Sept. 30, 2025 26.9 million
June 30, 2025 26.9 million

ETON Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 75000 1.9 million 10.4 million -
Dec. 31, 2025 49000 1.8 million 8.9 million -
Sept. 30, 2025 284000 1.1 million 8.1 million -
June 30, 2025 - 3.7 million 9.7 million -

ETON Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 24.3 million 9.5 million
Dec. 31, 2025 21.3 million 8.2 million
Sept. 30, 2025 22.5 million 14.6 million
June 30, 2025 18.9 million 7.0 million

ETON Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ETON

Price: $43.20

52 week price:
13.76
43.20

Payout Ratio Range:
-28.10%
-14.68%

Earnings Per Share: -0.06 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 36257

Market Capitalization: 1.0 billion

Links: